CD19 and myeloid sarcoma: When including CD4 + , CD8 + , and CD19 + cell counts to MS phenotype and MRI baseline activity in a logistic regression model predicting early inflammatory activity, CD8 + count was the only independent variable associated with outcome (OR 1.005 (1.001–1.009), p = 0.019).